View in EDS HTML Full Text PDF Full Text

Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.

Saved in:
Bibliographic Details
Title: Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.
Authors: Jiang DM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Parshad S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Zhan L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Sim HW; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, and NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Ausutralia., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Shapiro JD; Department of Medical Oncology, Cabrini Hospital, Cabrini Monash University, Melbourne, Australia., Price TJ; Department of Hematology and Oncology, Queen Elizabeth Hospital, CALHN, Adelaide, South Australia., Jonker DJ; Ottawa Hospital Research Institute, University of Ottawa, Ottawa ON., Karapetis CS; Flinders Medical Center, Flinders University, Adelaide, South Australia., Strickland AH; Monash Cancer Centre, Monash University, Clayton, Australia., Zhang W; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON., Jeffery M; Canterbury Regional Cancer and Hematology Service Centre, Christchurch Hospital, Christchurch, New Zealand., Tu D; Canadian Cancer Trials Group, Queen's University, Kingston, ON., Ng S; Sir Charles Gairdner Hospital, Nedlands, Australia., Sabesan S; Townsville Hospital, Townsville, Australia., Shannon J; Nepean Cancer Care Centre, Kingswood, Australia., Townsend A; Department of Hematology and Oncology, Queen Elizabeth Hospital, CALHN, Adelaide, South Australia., O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, ON., Chen EX; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON. Electronic address: eric.chen@uhn.ca.
Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2023 Dec; Vol. 22 (4), pp. 457-463. Date of Electronic Publication: 2023 Aug 23.
Publication Type: Randomized Controlled Trial; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37704538
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jiang+DM%22">Jiang DM</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.<br /><searchLink fieldCode="AU" term="%22Parshad+S%22">Parshad S</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.<br /><searchLink fieldCode="AU" term="%22Zhan+L%22">Zhan L</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.<br /><searchLink fieldCode="AU" term="%22Sim+HW%22">Sim HW</searchLink>; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, and NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Ausutralia.<br /><searchLink fieldCode="AU" term="%22Siu+LL%22">Siu LL</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.<br /><searchLink fieldCode="AU" term="%22Liu+G%22">Liu G</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.<br /><searchLink fieldCode="AU" term="%22Shapiro+JD%22">Shapiro JD</searchLink>; Department of Medical Oncology, Cabrini Hospital, Cabrini Monash University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Price+TJ%22">Price TJ</searchLink>; Department of Hematology and Oncology, Queen Elizabeth Hospital, CALHN, Adelaide, South Australia.<br /><searchLink fieldCode="AU" term="%22Jonker+DJ%22">Jonker DJ</searchLink>; Ottawa Hospital Research Institute, University of Ottawa, Ottawa ON.<br /><searchLink fieldCode="AU" term="%22Karapetis+CS%22">Karapetis CS</searchLink>; Flinders Medical Center, Flinders University, Adelaide, South Australia.<br /><searchLink fieldCode="AU" term="%22Strickland+AH%22">Strickland AH</searchLink>; Monash Cancer Centre, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.<br /><searchLink fieldCode="AU" term="%22Jeffery+M%22">Jeffery M</searchLink>; Canterbury Regional Cancer and Hematology Service Centre, Christchurch Hospital, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Tu+D%22">Tu D</searchLink>; Canadian Cancer Trials Group, Queen's University, Kingston, ON.<br /><searchLink fieldCode="AU" term="%22Ng+S%22">Ng S</searchLink>; Sir Charles Gairdner Hospital, Nedlands, Australia.<br /><searchLink fieldCode="AU" term="%22Sabesan+S%22">Sabesan S</searchLink>; Townsville Hospital, Townsville, Australia.<br /><searchLink fieldCode="AU" term="%22Shannon+J%22">Shannon J</searchLink>; Nepean Cancer Care Centre, Kingswood, Australia.<br /><searchLink fieldCode="AU" term="%22Townsend+A%22">Townsend A</searchLink>; Department of Hematology and Oncology, Queen Elizabeth Hospital, CALHN, Adelaide, South Australia.<br /><searchLink fieldCode="AU" term="%22O'Callaghan+CJ%22">O'Callaghan CJ</searchLink>; Canadian Cancer Trials Group, Queen's University, Kingston, ON.<br /><searchLink fieldCode="AU" term="%22Chen+EX%22">Chen EX</searchLink>; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON. Electronic address: eric.chen@uhn.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101120693%22">Clinical colorectal cancer</searchLink> [Clin Colorectal Cancer] 2023 Dec; Vol. 22 (4), pp. 457-463. <i>Date of Electronic Publication: </i>2023 Aug 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101120693 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215330028%22">15330028 </searchLink><i>NLM ISO Abbreviation: </i>Clin Colorectal Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37704538
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clcc.2023.08.006
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 457
    Titles:
      – TitleFull: Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jiang DM
      – PersonEntity:
          Name:
            NameFull: Parshad S
      – PersonEntity:
          Name:
            NameFull: Zhan L
      – PersonEntity:
          Name:
            NameFull: Sim HW
      – PersonEntity:
          Name:
            NameFull: Siu LL
      – PersonEntity:
          Name:
            NameFull: Liu G
      – PersonEntity:
          Name:
            NameFull: Shapiro JD
      – PersonEntity:
          Name:
            NameFull: Price TJ
      – PersonEntity:
          Name:
            NameFull: Jonker DJ
      – PersonEntity:
          Name:
            NameFull: Karapetis CS
      – PersonEntity:
          Name:
            NameFull: Strickland AH
      – PersonEntity:
          Name:
            NameFull: Zhang W
      – PersonEntity:
          Name:
            NameFull: Jeffery M
      – PersonEntity:
          Name:
            NameFull: Tu D
      – PersonEntity:
          Name:
            NameFull: Ng S
      – PersonEntity:
          Name:
            NameFull: Sabesan S
      – PersonEntity:
          Name:
            NameFull: Shannon J
      – PersonEntity:
          Name:
            NameFull: Townsend A
      – PersonEntity:
          Name:
            NameFull: O'Callaghan CJ
      – PersonEntity:
          Name:
            NameFull: Chen EX
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0674
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical colorectal cancer
              Type: main
ResultId 1